Baxdrostat demonstrated a statistically significant and clinically meaningful reduction of systolic blood pressure compared with placebo
This collaboration marks a significant milestone for Abluva as the company aims to deliver value and innovative solutions in agentic AI security
The Medical Countermeasures Strategy focuses on strengthening the EU’s preparedness for health crises
Certification bolsters Venus Remedies' position in PIC/S markets, reinforcing commitment to global quality standards
The CDMO upgrade represents a transformational step for Remedium Lifecare
Express Scripts has added YESINTEK to the National Preferred Formulary (NPF) effective March 21, 2025
A new weapon in the global fight against malaria
YESAFILI, a vascular endothelial growth factor (VEGF) inhibitor, is used to treat several different types of ophthalmology conditions
This registration authorizes Nureca Technologies to continue manufacturing and exporting asuite of medical devices to the United States
Subscribe To Our Newsletter & Stay Updated
